Hernandez, RosaSanchez-Jimenez, EsterMelguizo, ConsolacionPrados, JoseRama, Ana Rosa2023-01-252023-01-252018-07-10Hernández R, Sánchez-Jiménez E, Melguizo C, Prados J, Rama AR. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Rep. 2018 Nov;51(11):563-571.http://hdl.handle.net/10668/12882Colorectal cancer (CRC), the third most common cancer in the world, has no specific biomarkers that facilitate its diagnosis and subsequent treatment. The miRNAs, small single-stranded RNAs that repress the mRNA translation and trigger the mRNA degradation, show aberrant levels in the CRC, by which these molecules have been related with the initiation, progression, and drug-resistance of this cancer type. Numerous studies show the microRNAs influence the cellular mechanisms related to the cell cycle, differentiation, apoptosis, and migration of the cancer cells through the post-transcriptionally regulated gene expression. Specific patterns of the upregulated and down-regulated miRNA have been associated with the CRC diagnosis, prognosis, and therapeutic response. Concretely, the downregulated miRNAs represent attractive candidates, not only for the CRC diagnosis, but for the targeted therapies via the tumor-suppressing microRNA replacement. This review shows a general overview of the potential uses of the miRNAs in the CRC diagnosis, prognosis, and treatment with a special focus on the downregulated ones. [BMB Reports 2018; 51(11): 563-571].enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/BiomarkersColorectal cancerDiagnosismiRNATherapeutic targetBiomarkers, TumorColorectal NeoplasmsDown-RegulationGene Expression Regulation, NeoplasticHumansMicroRNAsPrognosisresearch article30158023open accessRegulación hacia abajoRegulación neoplásica de la expresión génicaPronósticoNeoplasias colorrectalesMicroARNsHumanosBiomarcadores de tumor10.5483/BMBRep.2018.51.11.1161976-670XPMC6283029http://www.bmbreports.org/journal/download_pdf.php?doi=10.5483/BMBRep.2018.51.11.116https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283029/pdf